CLINICAL_TRIALS
research
· 2007-01-24
Clinical Trial Update: T-Cell Vaccination in Multiple Sclerosis (MS) [Phase 1, Phase 2]
Summary
Update on a T-cell vaccination approach being explored for multiple sclerosis in Phase 1 and Phase 2 trials.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Sheba Medical Center | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: UNKNOWN